Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.54 CAD | +2.67% | -0.30% | -6.03% |
Mar. 22 | Dentalcorp Swings to Loss in Q4, Revenue Rises; Provides Outlook for Q1, Full-Year 2024; Down 1.2% | MT |
Mar. 22 | Transcript : Dentalcorp Holdings Ltd., Q4 2023 Earnings Call, Mar 22, 2024 |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company appears to be poorly valued given its net asset value.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- Low profitability weakens the company.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-6.03% | 877M | - | ||
-14.92% | 84.87B | B- | ||
+13.30% | 83.08B | C+ | ||
+10.92% | 29.4B | C+ | ||
-12.71% | 16.72B | B | ||
-3.06% | 16.4B | A- | ||
-2.63% | 15.04B | A- | ||
-3.97% | 11.88B | A- | ||
-1.42% | 11.88B | A- | ||
-31.75% | 11.86B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- DNTL Stock
- Ratings dentalcorp Holdings Ltd.